Dorsey Wright & Associates Buys 47,288 Shares of Sabra Healthcare REIT, Inc. $SBRA

Dorsey Wright & Associates boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 280.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 64,147 shares of the real estate investment trust’s stock after buying an additional 47,288 shares during the quarter. Dorsey Wright & Associates’ holdings in Sabra Healthcare REIT were worth $1,234,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Rothschild Investment LLC boosted its holdings in Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the last quarter. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $29,000. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT during the third quarter valued at about $30,000. Finally, Larson Financial Group LLC boosted its holdings in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $20.11 on Friday. The firm has a market cap of $5.07 billion, a price-to-earnings ratio of 31.92, a P/E/G ratio of 1.50 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT, Inc. has a 52 week low of $17.17 and a 52 week high of $21.28. The firm’s 50-day simple moving average is $19.60 and its two-hundred day simple moving average is $19.74.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the company earned $0.37 earnings per share. The company’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of recent analyst reports. Barclays started coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 price objective for the company. Cantor Fitzgerald boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Truist Financial raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a research report on Wednesday, July 8th. Finally, Citigroup lowered Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $24.00 to $19.00 in a report on Monday, June 22nd. Five analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $21.45.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.